$LFT
Lument Finance Trust, Inc. Stock $lft

$lft Overview Financials Valuation SEC Filings Company Website

2020 Q1 Form 10-Q Financial Statement

#000162828020007490 Filed on May 11, 2020

Income Statement

Concept	2020 Q1	2019 Q1
Revenue	$9.194M	$9.983M
YoY Change	-7.9%	-53.6%
Cost Of Revenue	$5.020M	$5.780M
YoY Change	-13.15%	-68.59%
Gross Profit	$4.180M	$3.500M
YoY Change	19.43%	1196.3%
Gross Profit Margin	45.46%	35.06%
Selling, General & Admin	$1.870M	$2.610M
YoY Change	-28.35%	-7.12%
% of Gross Profit	44.74%	74.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$2.167M	$2.648M
YoY Change	-18.16%	-17.58%
Operating Profit	$2.013M	$852.0K
YoY Change	136.27%	-128.95%
Interest Expense	$5.018M	$5.776M
YoY Change	-13.12%	-68.61%
% of Operating Profit	249.28%	677.93%
Other Income/Expense, Net	-$684.0K	-$147.0K
YoY Change	365.31%	-101.29%
Pretax Income	$1.330M	$1.410M
YoY Change	-5.67%	-87.54%
Income Tax	-$226.5K	-$63.00K
% Of Pretax Income	-17.03%	-4.47%
Net Earnings	$1.552M	$1.475M
YoY Change	5.2%	-86.96%
Net Earnings / Revenue	16.88%	14.78%
Basic Earnings Per Share
Diluted Earnings Per Share	$62.22K	$62.05K
COMMON SHARES
Basic Shares Outstanding	24.91M shares	23.68M shares
Diluted Shares Outstanding	24.91M shares	23.69M shares

Balance Sheet

Concept	2020 Q1	2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$11.30M	$13.60M
YoY Change	-16.91%	-67.85%
Cash & Equivalents	$11.33M	$13.64M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$13.70M	$16.20M
YoY Change	-15.43%	-91.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$6.900M	$52.50M
YoY Change	-86.86%	344.92%
Total Long-Term Assets	$650.3M	$643.2M
YoY Change	1.11%	-72.59%
TOTAL ASSETS
Total Short-Term Assets	$13.70M	$16.20M
Total Long-Term Assets	$650.3M	$643.2M
Total Assets	$664.0M	$659.4M
YoY Change	0.7%	-74.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$700.0K	$2.600M
YoY Change	-73.08%	1200.0%
Accrued Expenses	$600.0K	$1.000M
YoY Change	-40.0%	-83.33%
Deferred Revenue
YoY Change
Short-Term Debt	$506.4M	$504.5M
YoY Change	0.38%	-57.14%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$510.6M	$510.8M
YoY Change	-0.04%	-57.38%
LONG-TERM LIABILITIES
Long-Term Debt	$39.40M	$39.30M
YoY Change	0.25%	-96.71%
Other Long-Term Liabilities	$700.0K	$2.600M
YoY Change	-73.08%	766.67%
Total Long-Term Liabilities	$39.40M	$39.30M
YoY Change	0.25%	-96.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$510.6M	$510.8M
Total Long-Term Liabilities	$39.40M	$39.30M
Total Liabilities	$550.0M	$550.1M
YoY Change	-0.03%	-77.0%
SHAREHOLDERS EQUITY
Retained Earnings	$3.962M	-$2.364M
YoY Change	-267.6%	-115.37%
Common Stock	$249.3K	$236.8K
YoY Change	5.28%	0.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$114.0M	$109.2M
YoY Change
Total Liabilities & Shareholders Equity	$664.0M	$659.4M
YoY Change	0.7%	-74.06%

Cashflow Statement

Concept	2020 Q1	2019 Q1
OPERATING ACTIVITIES
Net Income	$1.552M	$1.475M
YoY Change	5.2%	-86.96%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$2.372M	$2.497M
YoY Change	-5.0%	32.12%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$4.110M	$7.190M
YoY Change	-157.16%	-87.97%
Cash From Investing Activities	-$4.106M	$7.191M
YoY Change	-157.09%	-87.96%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$5.747M	$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.970M	-$2.913M
YoY Change	-236.31%	-94.54%
NET CHANGE
Cash From Operating Activities	$2.372M	$2.497M
Cash From Investing Activities	-$4.106M	$7.191M
Cash From Financing Activities	$3.970M	-$2.913M
Net Change In Cash	$2.237M	$6.775M
YoY Change	-66.99%	-18.3%
FREE CASH FLOW
Cash From Operating Activities	$2.372M	$2.497M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2020Q1	dei	Amendment Flag AmendmentFlag	false
CY2020Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2020Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001547546
CY2020Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020Q1	dei	Document Type DocumentType	10-Q
CY2020Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2020Q1	dei	Document Period End Date DocumentPeriodEndDate	2020-03-31
CY2020Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q1	dei	Entity File Number EntityFileNumber	001-35845
CY2020Q1	dei	Entity Registrant Name EntityRegistrantName	HUNT COMPANIES FINANCE TRUST, INC.
CY2020Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MD
CY2020Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-4966519
CY2020Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	230 Park Avenue
CY2020Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	19th Floor
CY2020Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	New York
CY2020Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
CY2020Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	10169
CY2020Q1	dei	City Area Code CityAreaCode	212
CY2020Q1	dei	Local Phone Number LocalPhoneNumber	521-6323
CY2020Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020Q1	dei	Trading Symbol TradingSymbol	HCFT
CY2020Q1	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2020Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2020Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2020Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020Q1	dei	Entity Shell Company EntityShellCompany	false
CY2020Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	24938883	shares
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11334317	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10942115	USD
CY2020Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	6914097	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5069715	USD
CY2020Q1	us-gaap	Notes Receivable Net NotesReceivableNet	639366297	USD
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	635260420	USD
CY2020Q1	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	1822458	USD
CY2019Q4	oaks	Mortgage Service Rights At Fair Value MortgageServiceRightsAtFairValue	2700207	USD
CY2020Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	26667	USD
CY2019Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	40000	USD
CY2020Q1	us-gaap	Interest Receivable InterestReceivable	2423758	USD
CY2019Q4	us-gaap	Interest Receivable InterestReceivable	2342354	USD
CY2020Q1	us-gaap	Other Assets OtherAssets	2129619	USD
CY2019Q4	us-gaap	Other Assets OtherAssets	1547187	USD
CY2020Q1	us-gaap	Assets Assets	664017213	USD
CY2019Q4	us-gaap	Assets Assets	657901998	USD
CY2020Q1	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	506416518	USD
CY2019Q4	oaks	Collateralized Loan Obligations CollateralizedLoanObligations	505930065	USD
CY2020Q1	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39426846	USD
CY2019Q4	us-gaap	Secured Long Term Debt SecuredLongTermDebt	39384041	USD
CY2020Q1	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	564106	USD
CY2019Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	805126	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1874166	USD
CY2019Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1776912	USD
CY2020Q1	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	1013000	USD
CY2019Q4	us-gaap	Due To Related Parties Current And Noncurrent DueToRelatedPartiesCurrentAndNoncurrent	991981	USD
CY2020Q1	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	658436	USD
CY2019Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	369161	USD
CY2020Q1	us-gaap	Liabilities Liabilities	549953072	USD
CY2019Q4	us-gaap	Liabilities Liabilities	549257286	USD
CY2020Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24938883	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24938883	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	249344	USD
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	236877	USD
CY2020Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	233864573	USD
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	228135116	USD
CY2020Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	124111147	USD
CY2019Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	122236981	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	3961871	USD
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	2410200	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	113964641	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	108545212	USD
CY2020Q1	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2019Q4	us-gaap	Minority Interest MinorityInterest	99500	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114064141	USD
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108644712	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	664017213	USD
CY2020Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	9165805	USD
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	657901998	USD
CY2019Q1	us-gaap	Interest And Fee Income Loans Commercial Real Estate InterestAndFeeIncomeLoansCommercialRealEstate	9904188	USD
CY2020Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	0	USD
CY2019Q1	us-gaap	Interest Income Securities Mortgage Backed InterestIncomeSecuritiesMortgageBacked	78361	USD
CY2020Q1	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	28167	USD
CY2019Q1	us-gaap	Interest Income And Fees Bankers Acceptances Certificates Of Deposit And Commercial Paper InterestIncomeAndFeesBankersAcceptancesCertificatesOfDepositAndCommercialPaper	0	USD
CY2020Q1	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	4237889	USD
CY2019Q1	oaks	Interest Expense Collateralized Loan Obligations InterestExpenseCollateralizedLoanObligations	5446889	USD
CY2020Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	780441	USD
CY2019Q1	oaks	Interest Expense Secured Term Loan InterestExpenseSecuredTermLoan	329113	USD
CY2020Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4175642	USD
CY2019Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4206547	USD
CY2020Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	0	USD
CY2019Q1	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	-709439	USD
CY2020Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-877749	USD
CY2019Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-379998	USD
CY2020Q1	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	0	USD
CY2019Q1	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trusts UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrusts	694339	USD
CY2020Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	194147	USD
CY2019Q1	us-gaap	Fees And Commissions Mortgage Banking And Servicing FeesAndCommissionsMortgageBankingAndServicing	248214	USD
CY2020Q1	us-gaap	Other Income OtherIncome	2	USD
CY2019Q1	us-gaap	Other Income OtherIncome	0	USD
CY2020Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-683600	USD
CY2019Q1	oaks	Other Noninterest Income Loss OtherNoninterestIncomeLoss	-146884	USD
CY2020Q1	us-gaap	Management Fee Expense ManagementFeeExpense	584821	USD
CY2019Q1	us-gaap	Management Fee Expense ManagementFeeExpense	553459	USD
CY2020Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	765892	USD
CY2019Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1466685	USD
CY2020Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	461121	USD
CY2019Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	540037	USD
CY2020Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-300926	USD
CY2019Q1	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-37757	USD
CY2020Q1	us-gaap	Share Based Compensation ShareBasedCompensation	54132	USD
CY2019Q1	us-gaap	Share Based Compensation ShareBasedCompensation	50023	USD
CY2020Q1	us-gaap	Noninterest Expense NoninterestExpense	2166892	USD
CY2019Q1	us-gaap	Noninterest Expense NoninterestExpense	2647961	USD
CY2020Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1325150	USD
CY2019Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	1411702	USD
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-226521	USD
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-63065	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1474767	USD
CY2020Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	3750	USD
CY2019Q1	us-gaap	Preferred Stock Dividends And Other Adjustments PreferredStockDividendsAndOtherAdjustments	480472	USD
CY2020Q1	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
CY2019Q1	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	3093028	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1547921	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2098733	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1547921	USD
CY2019Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2098733	USD
CY2020Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	24911483	shares
CY2019Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23687664	shares
CY2020Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.06
CY2019Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
CY2020Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.08
CY2019Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.07
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	108644712	USD
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	5747375	USD
CY2020Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	13333	USD
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	7882	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1870416	USD
CY2020Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	114064141	USD
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	150203338	USD
CY2019Q1	oaks	Cost Of Issuing Of Common Stock Values CostOfIssuingOfCommonStockValues	22383	USD
CY2019Q1	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue	40250000	USD
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition	3773	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1474767	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1658136	USD
CY2019Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	480472	USD
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	109270887	USD
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1474767	USD
CY2020Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-273188	USD
CY2019Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-270184	USD
CY2020Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-13333	USD
CY2019Q1	oaks	Amortization Of Offering Costs AmortizationOfOfferingCosts	-22383	USD
CY2020Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	256069	USD
CY2019Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	232009	USD
CY2020Q1	oaks	Realized Gain Loss On Sale Of Investments RealizedGainLossOnSaleOfInvestments	0	USD
CY2019Q1	oaks	Realized Gain Loss On Sale Of Investments RealizedGainLossOnSaleOfInvestments	-709439	USD
CY2020Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-877749	USD
CY2019Q1	oaks	Unrealized Gain Loss On Mortgage Service Rights UnrealizedGainLossOnMortgageServiceRights	-379998	USD
CY2020Q1	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust	0	USD
CY2019Q1	oaks	Unrealized Gain Loss On Multifamily Loans Held In Securitization Trust UnrealizedGainLossOnMultifamilyLoansHeldInSecuritizationTrust	694339	USD
CY2020Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	7882	USD
CY2019Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	3773	USD
CY2020Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	81404	USD
CY2019Q1	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	180869	USD
CY2020Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-13333	USD
CY2019Q1	us-gaap	Increase Decrease In Deferred Charges IncreaseDecreaseInDeferredCharges	-22383	USD
CY2020Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	582432	USD
CY2019Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	302767	USD
CY2020Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-241020	USD
CY2019Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	149854	USD
CY2020Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	21019	USD
CY2019Q1	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-128564	USD
CY2020Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	289276	USD
CY2019Q1	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	583418	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2371998	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	2496903	USD
CY2020Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	38613756	USD
CY2019Q1	us-gaap	Payments To Acquire Loans Held For Investment PaymentsToAcquireLoansHeldForInvestment	64612349	USD
CY2020Q1	oaks	Repayments Of Principal To Repurchase Mortgage Loans Heldforsale RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale	0	USD
CY2019Q1	oaks	Repayments Of Principal To Repurchase Mortgage Loans Heldforsale RepaymentsOfPrincipalToRepurchaseMortgageLoansHeldforsale	-4747049	USD
CY2020Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	34507879	USD
CY2019Q1	us-gaap	Proceeds From Principal Repayments On Loans And Leases Held For Investment ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment	34014437	USD
CY2020Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	0	USD
CY2019Q1	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-33042234	USD
CY2020Q1	oaks	Proceeds From Broker Investing Activities ProceedsFromBrokerInvestingActivities	0	USD
CY2019Q1	oaks	Proceeds From Broker Investing Activities ProceedsFromBrokerInvestingActivities	0	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4105877	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	7191371	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	5747375	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	0	USD
CY2019Q1	us-gaap	Payments For Repurchase Of Redeemable Preferred Stock PaymentsForRepurchaseOfRedeemablePreferredStock	40250000	USD
CY2020Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1776912	USD
CY2019Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	1421259	USD
CY2020Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	0	USD
CY2019Q1	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	521114	USD
CY2020Q1	oaks	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	0	USD
CY2019Q1	oaks	Proceeds From Collateralized Loan Obligations ProceedsFromCollateralizedLoanObligations	0	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2019Q1	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	40250000	USD
CY2020Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	970545	USD
CY2020Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3970463	USD
CY2019Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2912918	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2236584	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6775356	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16011830	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59213812	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18248414	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	65989168	USD
CY2020Q1	us-gaap	Interest Paid Net InterestPaidNet	4730094	USD
CY2019Q1	us-gaap	Interest Paid Net InterestPaidNet	4965785	USD
CY2020Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1874166	USD
CY2019Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	1661844	USD
CY2020Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:120%;">Use of Estimates</span></div><div style="text-indent:18pt;text-align:justify;"><span><br/></span></div><div style="text-indent:18pt;text-align:justify;"><span style="background-color:rgb(255,255,255, 0.0);color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;">The financial statements have been prepared on the accrual basis of accounting in accordance with GAAP. The preparation of financial statements in conformity with GAAP requires the Company to make a number of significant estimates. The first quarter of 2020 was impacted by the global outbreak of a novel coronavirus ("COVID-19"), which has spread to over 200 countries and territories, including the United States, and has spread to every state in the United States. On March 11, 2020, the World Health Organization ("WHO") declared COVID-19 a pandemic, and numerous countries, including the United States, have issued wide ranging responses including the imposition of quarantines, "stay-at-home" orders, restrictions on travel, closing financial markets and other similar mandates. The outbreak could have a continued adverse impact on economic and market conditions and trigger a period of global economic slowdown. The prolonged duration of the COVID-19 pandemic and its impact on our borrowers and their tenants, cash flows and future results of operations </span></div>could be significant and will largely depend on future developments, which are highly uncertain and cannot be predicted. We believe the estimates and assumptions underlying our consolidated financial statements are reasonable and supportable based on the information available as of March 31, 2020, however uncertainty over the ultimate impact of COVID-19 on the global economy generally, and our business in particular, makes any estimates and assumptions inherently less certain than they would be absent the current and potential impacts of COVID-19. Actual results could differ from its estimates and the differences may be material.
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11334317	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10942115	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	18248414	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16011830	USD
CY2020Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	0	USD
CY2020Q1	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	0	USD
CY2020Q1	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	0	USD
CY2020Q1	us-gaap	Accumulated Amortization Deferred Finance Costs AccumulatedAmortizationDeferredFinanceCosts	1017419	USD
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24938883	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24938883	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2019Q4	oaks	Income Tax Examination Accrued Tax Liability IncomeTaxExaminationAccruedTaxLiability	1960000	USD
CY2020Q1	oaks	One Month Libor Rate OneMonthLIBORRate	0.0138	USD
CY2019Q4	oaks	One Month Libor Rate OneMonthLIBORRate	0.0170	USD
CY2020Q1	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0160	USD
CY2019Q4	oaks	Weighted Average Libor Floor Rate WeightedAverageLIBORFloorRate	0.0156	USD
CY2018Q2	oaks	Number Of Loan Participations NumberOfLoanParticipations	8	Loan_Participation
CY2019Q1	oaks	Collateralized Loan Obligation Unamortized Discount CollateralizedLoanObligationUnamortizedDiscount	39200000	USD
CY2020Q1	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	823154	USD
CY2019Q4	oaks	Collateralized Loan Obligation Deferred Financing Costs CollateralizedLoanObligationDeferredFinancingCosts	865959	USD
CY2020Q1	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q1	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2020Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2019Q4	us-gaap	Secured Debt SecuredDebt	40250000	USD
CY2019Q4	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40250000	USD
CY2020Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1822458	USD
CY2019Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	2700207	USD
CY2019	oaks	Management Fee Percentage ManagementFeePercentage	0.015
CY2020Q1	us-gaap	Management Fee Expense ManagementFeeExpense	584821	USD
CY2019Q1	us-gaap	Management Fee Expense ManagementFeeExpense	553459	USD
CY2020Q1	us-gaap	Management Fee Payable ManagementFeePayable	566000	USD
CY2019Q1	us-gaap	Management Fee Payable ManagementFeePayable	567000	USD
CY2020Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	461121	USD
CY2019Q1	oaks	Reimbursable Operating Expense ReimbursableOperatingExpense	540037	USD
CY2020Q1	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	447000	USD
CY2019Q1	oaks	Reimbursable Costs Payable ReimbursableCostsPayable	479436	USD
CY2020Q1	oaks	Exit Fee Waived Percentage Reduced ExitFeeWaivedPercentageReduced	0.50
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	450000000	shares
CY2020Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24938883	shares
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24938883	shares
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24938883	shares
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23692164	shares
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23692164	shares
CY2015Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	10000000	USD
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	50000000	shares
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1610000	shares
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	1610000	shares
CY2020Q1	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.0875
CY2019Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	25.00
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	1551671	USD
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	1474767	USD
CY2020Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1870416	USD
CY2019Q1	us-gaap	Dividends Common Stock DividendsCommonStock	1658136	USD
CY2020Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	3750	USD
CY2019Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	480472	USD
CY2020Q1	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	0	USD
CY2019Q1	oaks	Deemed Preferred Stock Dividend On Related Redemptions DeemedPreferredStockDividendOnRelatedRedemptions	3093028	USD
CY2020Q1	us-gaap	Dividends Dividends	1874166	USD
CY2019Q1	us-gaap	Dividends Dividends	5231636	USD
CY2020Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-322495	USD
CY2019Q1	us-gaap	Undistributed Earnings Loss Available To Common Shareholders Basic UndistributedEarningsLossAvailableToCommonShareholdersBasic	-3756869	USD
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24906983	shares
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23683164	shares
CY2020Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2019Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	4500	shares
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24911483	shares
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23687664	shares
CY2018Q4	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	1960000	USD

Files In Submission

Name	View Source	Status
0001628280-20-007490-index-headers.html	Edgar Link	pending
0001628280-20-007490-index.html	Edgar Link	pending
0001628280-20-007490.txt	Edgar Link	pending
0001628280-20-007490-xbrl.zip	Edgar Link	pending
a20200331exhibit31-1.htm	Edgar Link	pending
a20200331exhibit31-2.htm	Edgar Link	pending
a20200331exhibit32-1.htm	Edgar Link	pending
a20200331exhibit32-2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
oaks-20200331.htm	Edgar Link	pending
oaks-20200331.xsd	Edgar Link	pending
oaks-20200331_cal.xml	Edgar Link	unprocessable
oaks-20200331_def.xml	Edgar Link	unprocessable
oaks-20200331_htm.xml	Edgar Link	completed
oaks-20200331_lab.xml	Edgar Link	unprocessable
oaks-20200331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LFT
Lument Finance Trust, Inc. Stock $lft

2020 Q1 Form 10-Q Financial Statement

#000162828020007490 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT Lument Finance Trust, Inc. Stock $lft

2020 Q1 Form 10-Q Financial Statement

#000162828020007490 Filed on May 11, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LFT
Lument Finance Trust, Inc. Stock $lft